ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Gore, Agency Report, Support Legislation To Protect Genetic Info

January 30, 1998

Pursuit Of Truth Was Not An NIH Objective In Gallo Case, Dingell Staff Report Says

January 6, 1995

NCI To Fund 160 P01s FY91, About same As Last Year; Considering New ‘Interactive’ R01

June 21, 1991

Health Organizations: ACS Advises annual Prostate Screening for some Younger Men

June 20, 1997

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002